Clincosm LogoSign in Get a demo

Malignant Melanoma

Showing NaN - NaN of 32
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Advanced Solid Tumor, Castration-Resistant Prostatic Cancer, Malignant Melanoma Trial in United States (MGC018, lorigerlimab)

Recruiting
  • Advanced Solid Tumor
  • +6 more
  • vobramitamab duocarmazine
  • lorigerlimab
  • Los Angeles, California
  • +7 more
Jan 10, 2023

Malignant Melanoma, NSCLC, Brain Tumors, Primary Trial in United States (PF-07284890, Binimetinib, Midazolam)

Recruiting
  • Malignant Melanoma
  • +4 more
  • Duarte, California
  • +71 more
Dec 29, 2022

Malignant Melanoma Trial in Worldwide (Pembrolizumab, Lenvatinib, Placebo for lenvatinib)

Active, not recruiting
  • Malignant Melanoma
  • Pembrolizumab
  • +2 more
  • Los Angeles, California
  • +118 more
Aug 22, 2022

Malignant Melanoma Trial in Los Angeles, Houston, Uppsala (delolimogene mupadenorepvec, atezolizumab)

Recruiting
  • Malignant Melanoma
  • delolimogene mupadenorepvec
  • atezolizumab
  • Los Angeles, California
  • +2 more
Apr 4, 2022

PET Imaging of the Immune System Using Analog Probes

Completed
  • Malignant Melanoma
  • [18F] CFA
  • Los Angeles, California
    University of California, Los Angeles
Oct 8, 2021

Malignant Melanoma, Medullary Thyroid Cancer, Glioblastoma Trial in United States (Rovalpituzumab tesirine, Dexamethasone)

Terminated
Has Results
  • Malignant Melanoma
  • +7 more
  • Gilbert, Arizona
  • +29 more
Sep 21, 2020

Malignant Melanoma Trial in Worldwide (Placebo, Vemurafenib, Cobimetinib)

Completed
Has Results
  • Malignant Melanoma
  • Placebo
  • +2 more
  • Birmingham, Alabama
  • +155 more
Sep 14, 2020

Malignant Melanoma Trial in United States (Atezolizumab, Cobimetinib, Vemurafenib)

Completed
  • Malignant Melanoma
  • Los Angeles, California
  • +7 more
Jul 20, 2020

Malignant Melanoma Trial in United Kingdom, United States (IMCgp100)

Completed
Has Results
  • Malignant Melanoma
  • Los Angeles, California
  • +8 more
Jul 1, 2020

Lymphoma, Non-Hodgkin, Lymphoma, Follicular, Lymphoma, Large B-Cell, Diffuse Trial in Worldwide (PF-05082566, rituximab)

Completed
Has Results
  • Lymphoma, Non-Hodgkin
  • +6 more
  • Duarte, California
  • +41 more
Mar 4, 2020

Malignant Melanoma Trial in Worldwide (ABI-007, Dacarbazine)

Completed
Has Results
  • Malignant Melanoma
  • Birmingham, Alabama
  • +111 more
Oct 16, 2019

Malignant Melanoma Trial in Australia, United States (Cobimetinib, vemurafenib)

Completed
Has Results
  • Malignant Melanoma
  • Los Angeles, California
  • +9 more
Jul 26, 2019

Malignant Melanoma Trial in Worldwide (Ipilimumab)

Terminated
Has Results
  • Malignant Melanoma
  • Ipilimumab
  • Phoenix, Arizona
  • +31 more
Jul 31, 2017

Malignant Melanoma, Colorectal Carcinoma Trial in Australia, United States (PLX4032)

Completed
Has Results
  • Malignant Melanoma
  • Colorectal Carcinoma
  • Los Angeles, California
  • +6 more
Aug 18, 2017

Malignant Melanoma Trial in United States (Drug cocktail, RO5185426)

Completed
Has Results
  • Malignant Melanoma
  • Los Angeles, California
  • +4 more
Jul 6, 2017

Malignant Melanoma Trial in Australia, United States (vemurafenib)

Completed
Has Results
  • Malignant Melanoma
  • Los Angeles, California
  • +14 more
Jun 26, 2017

Malignant Melanoma Trial in United States (Vemurafenib)

Terminated
Has Results
  • Malignant Melanoma
  • Tucson, Arizona
  • +14 more
Apr 24, 2017

Malignant Melanoma Trial in Canada, United States (Nivolumab, Ipilimumab)

No longer available
  • Malignant Melanoma
  • Gilbert, Arizona
  • +65 more
Feb 6, 2017

Malignant Melanoma Trial in Australia, United States (DEDN6526A)

Completed
  • Malignant Melanoma
  • Los Angeles, California
  • +5 more
Nov 1, 2016

Malignant Melanoma Trial in United States (RO5185426)

Completed
Has Results
  • Malignant Melanoma
  • La Jolla, California
  • +9 more
Nov 1, 2016

Malignant Melanoma Trial in Worldwide (vemurafenib)

Terminated
Has Results
  • Malignant Melanoma
  • Los Angeles, California
  • +25 more
Aug 25, 2016

Malignant Melanoma Trial in Worldwide (Ipilimumab+ Placebo, Ipilimumab+ Budesonide)

Completed
  • Malignant Melanoma
  • Ipilimumab+ Placebo
  • Ipilimumab+ Budesonide
  • Los Angeles, California
  • +9 more
Sep 26, 2016

Malignant Melanoma Trial in Worldwide (Vemurafenib, Dacarbazine)

Completed
Has Results
  • Malignant Melanoma
  • Birmingham, Alabama
  • +110 more
Aug 19, 2016

Malignant Melanoma Trial in United States (RO5185426)

Completed
Has Results
  • Malignant Melanoma
  • Tucson, Arizona
  • +27 more
Jul 12, 2016

Malignant Melanoma Trial in Worldwide (Vemurafenib)

Completed
Has Results
  • Malignant Melanoma
  • Los Angeles, California
  • +32 more
Jun 20, 2016